149 related articles for article (PubMed ID: 24346849)
1. Pharmacokinetic-pharmacodynamic evaluation of the major component astragaloside IV on the immunomodulatory effects of Yu-ping-feng prescription.
Song J; Li J; Jin Y; Wang H; Zheng S; Gao J
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):103-10. PubMed ID: 24346849
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats.
Song J; Zheng SR; Jin Y; Li J
Planta Med; 2014 Feb; 80(2-3):187-92. PubMed ID: 24452462
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and immunoregulatory effects of Yupingfeng powder on chronic bronchitis rats.
Song J; Li J; Zheng SR; Jin Y; Huang Y
Chin J Integr Med; 2013 May; 19(5):353-9. PubMed ID: 23504545
[TBL] [Abstract][Full Text] [Related]
4. Analysis of immunostimulatory activity of polysaccharide extracted from Yu-Ping-Feng in vitro and in vivo.
Fan W; Zheng P; Wang Y; Hao P; Liu J; Zhao X
Biomed Pharmacother; 2017 Sep; 93():146-155. PubMed ID: 28628831
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis.
Wang JJ; Li J; Shi L; Lv XW; Cheng WM; Chen YY
J Pharm Pharmacol; 2010 Jul; 62(7):935-42. PubMed ID: 20636883
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulating effects of fractioned polysaccharides isolated from Yu-Ping-Feng-Powder in cyclophosphamide-treated mice.
Chen XT; Li J; Wang HL; Cheng WM; Zhang L; Ge JF
Am J Chin Med; 2006; 34(4):631-41. PubMed ID: 16883634
[TBL] [Abstract][Full Text] [Related]
7. Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor Cells.
Wang Y; Sun N; Luo Y; Fang Z; Fang Y; Tian J; Yu Y; Wu J; Li Y
Evid Based Complement Alternat Med; 2021; 2021():6624461. PubMed ID: 33986819
[TBL] [Abstract][Full Text] [Related]
8. The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues.
Chang YX; Sun YG; Li J; Zhang QH; Guo XR; Zhang BL; Jin H; Gao XM
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():71-5. PubMed ID: 23217309
[TBL] [Abstract][Full Text] [Related]
9. Using UPLC-MS/MS for Characterization of Active Components in Extracts of Yupingfeng and Application to a Comparative Pharmacokinetic Study in Rat Plasma after Oral Administration.
Jia MQ; Xiong YJ; Xue Y; Wang Y; Yan C
Molecules; 2017 May; 22(5):. PubMed ID: 28513568
[TBL] [Abstract][Full Text] [Related]
10. Effects of Gancao on pharmacokinetic profiles of platycodin D and deapio-platycodin D in Jiegeng.
Shan JJ; Zou JS; Xie T; Kang A; Zhou W; Xu JY; Shen CS; Du LN; Wang SC; Di LQ
J Ethnopharmacol; 2015 Jul; 170():50-6. PubMed ID: 25980422
[TBL] [Abstract][Full Text] [Related]
11. [Experimental studies on pharmacokinetics of three components in Buyanghuanwu injection on base of total quantum statistical moment].
He FY; Deng KW; Liu WL; Shi JL; Wu Y; Liu W; He QP; Li B
Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):253-62. PubMed ID: 23672052
[TBL] [Abstract][Full Text] [Related]
12. Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism.
Zhang H; Song J; Dai H; Liu Y; Wang L
Pharm Biol; 2020 Dec; 58(1):328-332. PubMed ID: 32356474
[No Abstract] [Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modeling to study the anti-dysmenorrhea effect of Guizhi Fuling capsule on primary dysmenorrhea rats.
Cheng Y; Chu Y; Su X; Zhang K; Zhang Y; Wang Z; Xiao W; Zhao L; Chen X
Phytomedicine; 2018 Sep; 48():141-151. PubMed ID: 30195872
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of astragaloside iv in beagle dogs.
Zhang Q; Zhu LL; Chen GG; Du Y
Eur J Drug Metab Pharmacokinet; 2007; 32(2):75-9. PubMed ID: 17702194
[TBL] [Abstract][Full Text] [Related]
15. Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali.
Gu Y; Wang G; Pan G; Fawcett JP; A J; Sun J
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):295-8. PubMed ID: 15569275
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic comparison of seven major bio-active components in normal and blood deficiency rats after oral administration of Danggui Buxue decoction by UPLC-TQ/MS.
Shi X; Tang Y; Zhu H; Li W; Li W; Li Z; Luo N; Duan JA
J Ethnopharmacol; 2014 Apr; 153(1):169-77. PubMed ID: 24583239
[TBL] [Abstract][Full Text] [Related]
17. Comparative tissue distribution profiles of five major bio-active components in normal and blood deficiency rats after oral administration of Danggui Buxue Decoction by UPLC-TQ/MS.
Shi X; Tang Y; Zhu H; Li W; Li Z; Li W; Duan JA
J Pharm Biomed Anal; 2014 Jan; 88():207-15. PubMed ID: 24076576
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Astragaloside IV in rats by liquid chromatography coupled with tandem mass spectrometry.
Du Y; Zhang Q; Chen GG; Wei P; Tu CY
Eur J Drug Metab Pharmacokinet; 2005; 30(4):269-73. PubMed ID: 16435572
[TBL] [Abstract][Full Text] [Related]
19. Yu-Ping-Feng Formula Ameliorates Alveolar-Capillary Barrier Injury Induced by Exhausted-Exercise
Wang D; Li Q; Pan CS; Yan L; Sun K; Wang XY; Anwaier G; Liao QZ; Xie TT; Fan JY; Huo XM; Wang Y; Han JY
Front Pharmacol; 2022; 13():891802. PubMed ID: 35814249
[No Abstract] [Full Text] [Related]
20. An HPLC-MS/MS method for the quantitative determination of platycodin D in rat plasma and its application to the pharmacokinetics of Platycodi Radix extract.
Zhan Q; Zhang F; Gao SH; Cai F; Jiang B; Sun LN; Chen WS
Chin J Nat Med; 2014 Feb; 12(2):154-60. PubMed ID: 24636069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
